4126.0: Tuesday, October 23, 2001 - 12:45 PM

Abstract #21413

Hepatitis C and syphilis seroprevalence among clients attending anonymous HIV testing and counseling sites, San Diego, CA, 2000-2001

Robert A. Gunn, MD MPH1, Paula Murray, MPH2, Denise Borntrager, BS2, and Carolyn Brennan, MPH2. (1) STD Control Program, Centers for Disease Control and Prevention, HHSA San Diego County, 3851 Rosecrans St, San Diego, CA 92110, 619-692-8614, rgunnxhe@co.san-diego.ca.us, (2) STD Control Program, HHSA San Diego County, 3851 Rosecrans St, San Diego, CA 92110

OBJECTIVE: To determine the risk factors for hepatitis C virus (HCV) and syphilis infection and to evaluate the process of integrating confidential testing at anonymous human immunodeficiency virus (HIV) counseling and testing sites.

METHODS: All clients attending anonymous HIV counseling and testing sites were offered HCV screening (began Oct 2000) and hepatitis B vaccination (began Jan 2001) and men who have sex with men (MSM) were offered syphilis screening (began Jun 2000) and hepatitis A vaccination (began Jan 2001). Persons who were HCV positive (RIBA confirmed) were offered follow-up assistance at 1, 3 and 6 months. The screening process will be evaluated from both the clients’ and counselors’ perspective.

RESULTS: Of the 568 clients screened for syphilis, 7 (1.2%) were infected, but none had early syphilis. Of the 1,253 visits recorded (Oct - Dec 2000), 459 (36.6%) persons accepted screening for HCV and 29 (6.3%) were positive. Among injection drug users (IDU), the HCV prevalence was 48.6% (17/35) which was 17 times that of non-IDUs (2.8%, 12/424, p=<0.001). Among non-IDU MSM, the HCV prevalence was also 2.8% (5/178). No clients refused HIV testing because confidential services were offered on site. Additional seroprevalence, hepatitis A and B vaccination acceptance, and HCV case follow-up data through Aug 2001 will be presented.

CONCLUSION: Many clients seeking anonymous HIV testing accepted confidential HCV and syphilis testing which suggest that other services such as selective hepatitis A and universal hepatitis B vaccination and urine testing for chlamydia and gonorrhea could be integrated into services at these sites.

Learning Objectives: 1. Participants will learn the risk factors for hepatitis C and syphilis among clients attending anonymous HIV counseling and testing sites 2. Participants will learn about the process of intergrating confidential testing at an anonymous service.

Keywords: Hepatitis C, HIV/AIDS

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
Disclosure not received
Relationship: Not Received.

The 129th Annual Meeting of APHA